Latest Regulatory News

Tryptamine Therapeutics has locked in $2.6 million in non-dilutive funding to fast-track clinical trials of its lead psilocin-based therapy, TRP-8803, targeting binge eating disorder and other conditions.

AJ Lucas Group’s UK arm Cuadrilla Resources has settled a long-standing dispute over shale gas licences, receiving £12.5 million and terminating the carry agreement. This resolution clears a financial uncertainty clouding the company’s UK operations.

Audeara Limited has secured a five-year licensing agreement with Eastech (Huizhou) Co., Ltd. to bring its advanced hearing technology to China’s booming medical device market, leveraging major e-commerce platforms for distribution.

James Bay Minerals has reported significant high-grade gold and silver mineralisation extensions at its Independence Project in Nevada, challenging previous resource boundaries and prompting a strategic shift in exploration focus.

Northern Star Resources has completed its due diligence on Mantle Minerals’ Mt Roe subsidiary acquisition, paving the way for settlement within days.

Helix Resources Limited has announced a renounceable pro-rata entitlement offer to raise approximately $1.68 million, partially underwritten by Mahe Capital, aiming to fund key drilling and resource estimation projects.

Spark New Zealand is selling 75% of its data centre business to Pacific Equity Partners for up to $705 million, aiming to accelerate capacity expansion amid rising cloud and AI demand.

Seven West Media reports a robust 33% rise in underlying net profit, driven by a 26% jump in 7plus digital revenue, even as traditional TV advertising revenue declines by 4%.

Envirosuite Limited’s shares will be suspended from ASX trading following Federal Court approval of its acquisition by Ideagen EVS BidCo Pty Limited. This marks a pivotal step in the environmental software company’s transition under new ownership.

GTN Limited has finalised a $43.85 million capital return, distributing $0.23 per share to shareholders. The company awaits an Australian Tax Office ruling to clarify tax implications for investors.

Imagion Biosystems has completed the first tranche of its $3.5 million capital raising, issuing 45 million new shares to strengthen its financial position ahead of a key shareholder vote.

Peak Rare Earths Limited shareholders are set to vote on a scheme of arrangement proposing acquisition by Shenghe Resources (Singapore) Pte. Ltd., valuing Peak at approximately A$158 million and offering a substantial premium over recent trading prices.